Intra-arterial Versus Intravenous Chemoradiation for Advanced Head and Neck Cancer: Results of a Randomized Phase 3 Trial (vol 116, pg 2159, 2010)

被引：2
|
作者：
Rasch, C. R. N. [1 ]
Hauptmann, M. [1 ]
Schornagel, J. [1 ]
Wijers, O. [1 ]
Buter, J. [1 ]
Gregor, T. [1 ]
Wiggenraad, R. [1 ]
de Boer, J. P. [1 ]
Ackerstaff, A. H. [1 ]
Kroger, R. [1 ]
Hoebers, F. J. P. [1 ]
Balm, A. J. M. [1 ]
Hilgers, Frans J. [1 ]
机构：
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Ctr, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands
来源：
CANCER | 2010年 / 116卷 / 15期
关键词：
D O I：
10.1002/cncr.25234
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3750 / 3750
页数：1
相关论文
共 50 条
  • [21] Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.
    Ikeda, Masafumi
    Shimizu, Satoshi
    Sato, Tosiya
    Morimoto, Manabu
    Inaba, Yoshitaka
    Kojima, Yasushi
    Hagihara, Atsushi
    Kudo, Masatoshi
    Nakamori, Shoji
    Kaneko, Shuichi
    Sugimoto, Rie
    Tahara, Toshiyuki
    Ohmura, Takumi
    Yasui, Kohichiroh
    Sato, Keiko
    Ishii, Hiroshi
    Furuse, Junji
    Okusaka, Takuji
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
    Pirus Ghadjar
    Stefanie Hayoz
    Frank Zimmermann
    Stephan Bodis
    David Kaul
    Harun Badakhshi
    Jacques Bernier
    Gabriela Studer
    Ludwig Plasswilm
    Volker Budach
    Daniel M Aebersold
    Radiation Oncology, 10
  • [23] Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
    Ghadjar, Pirus
    Hayoz, Stefanie
    Zimmermann, Frank
    Bodis, Stephan
    Kaul, David
    Badakhshi, Harun
    Bernier, Jacques
    Studer, Gabriela
    Plasswilm, Ludwig
    Budach, Volker
    Aebersold, Daniel M.
    RADIATION ONCOLOGY, 2015, 10
  • [24] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer (vol 18, pg 3339, 2000)
    Brizel
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) : 4110 - 4111
  • [25] INTRA-ARTERIAL CIS-PLATINUM IN HEAD AND NECK CANCER-CONTROLLED CLINICAL-TRIAL IN PHASE-I AND PHASE-II
    GALMARINI, FC
    YOEL, J
    ABULAFIA, J
    NAKASONE, J
    TEMPERLEY, G
    HEAD & NECK SURGERY, 1981, 3 (03): : 257 - 257
  • [26] Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94)
    Ghadjar, Pirus
    Sun, Hong
    Zimmermann, Frank
    Bodis, Stephan
    Bernier, Jacques
    Studer, Gabriela
    Aebersold, Daniel M.
    ORAL ONCOLOGY, 2013, 49 (10) : 1006 - 1009
  • [27] Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
    Patil, Vijay Maruti
    Noronha, Vanita
    Menon, Nandini
    Singh, Ajay
    Ghosh-Laskar, Sarbani
    Budrukkar, Ashwini
    Bhattacharjee, Atanu
    Swain, Monali
    Mathrudev, Vijayalakshmi
    Nawale, Kavita
    Balaji, Arun
    Peelay, Zoya
    Alone, Mitali
    Pathak, Shruti
    Mahajan, Abhishek
    Kumar, Suman
    Purandare, Nilendu
    Agarwal, Archi
    Puranik, Ameya
    Pendse, Shantanu
    Yallala, Monica Reddy
    Sahu, Harsh
    Kapu, Venkatesh
    Dey, Sayak
    Choudhary, Jatin
    Krishna, Madala Ravi
    Shetty, Alok
    Karuvandan, Naveen
    Ravind, Rahul
    Rai, Rahul
    Jobanputra, Kunal
    Chaturvedi, Pankaj
    Pai, Prathamesh S.
    Chaukar, Devendra
    Nair, Sudhir
    Thiagarajan, Shivakumar
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13) : 2350 - +
  • [28] Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial
    Vozy, A.
    Cuenca, X.
    ONCOLOGIE, 2016, 18 (06) : 429 - 430
  • [29] Phase 2b Randomized Trial Comparing Concurrent Chemoradiation With Weekly Versus 3 Weekly Cisplatinum in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Kumar, R. R.
    Haridas, G.
    Kainickal, C. T.
    Sudha, A. S.
    Rafi, M.
    Raghavan, R.
    Ramadas, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S566 - S566
  • [30] Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.
    Noronha, Vanita
    Joshi, Amit
    Patil, Vijay Maruti
    Agarwal, Jaiprakash
    Laskar, Sarbani Ghosh
    Budrukkar, Ashwini Narsingrao
    Murthy, Vedang
    Gupta, Tejpal
    D'Cruz, Anil
    Pai, P. S.
    Chaturvedi, Pankaj
    Chaukar, Devendra
    Pande, Nikhil
    Chandrasekharan, Arun
    Talreja, Vikas
    Vallathol, Dilip
    Manjrekar, Aparna
    Mathrudev, Vijayalakshmi
    Maske, Kamesh
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345